ZENITH HEALTH CARE LTD.

Zenith Healthcare Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the second quarter and half-year ending September 30, 2026. The specific date for the board meeting to consider these financial results will be communicated later.

Zenith Healthcare Ltd announced the reappointment of Mrs. Neela M. Raycha as a Non-Executive Director. She retires by rotation at the upcoming 32nd Annual General Meeting and is eligible for re-appointment. Mrs. Raycha, a Science Graduate with expertise in Quality Control and Product Development, has been a director since March 13, 2001. She holds 1261712 shares and is not debarred from holding directorships.

Zenith Healthcare Ltd has announced the regularization of Mr. Akshit M. Raycha (DIN: 03039859) as Joint Managing Director/Whole Time Director. This decision was approved by a special resolution at the company's 32nd Annual General Meeting. Mr. Raycha, son of CMD Mahendra C. Raycha, has been with the company in this role and has initiated several new business initiatives. His term is set from May 29, 2026, to April 28, 2029. His remuneration will be up to ₹2,00,000 per month, with an annual increase of ₹9,00,000, bringing the total to ₹24,00,000.

Zenith Healthcare Ltd announced the re-appointment of Mr. Mahendra C. Raycha (DIN:00577647) as Managing Director for a fresh term of three years, from July 1, 2026, to June 30, 2029. This decision was approved by way of a special resolution at the company's 32nd Annual General Meeting. Mr. Raycha, who is also a promoter holding 12.29% equity, has over 20 years of experience as MD. The company cited his continued physical and mental fitness, extensive experience, and contribution to the company's growth and zero-debt status as reasons for his reappointment. His remuneration will be up to ₹2,00,000 per month plus other perquisites as per agreement.

Zenith Healthcare Limited conducted its 32nd Annual General Meeting on August 28, 2026, via Video Conferencing. Key businesses transacted included the approval of the Audited Financial Statements for the year ended March 31, 2026, the re-appointment of a director retiring by rotation, the re-appointment of Mr. Mahendra C. Raycha as Managing Director, and the regularization of Mr. Akshit M. Raycha as Joint Managing Director/Whole Time Director. Additionally, the company sought approval for a material related party transaction with Achyut Healthcare Limited. The meeting was brief, concluding in 14 minutes, with 39 shareholders attending virtually. The statutory auditors' and secretarial auditors' reports had no qualifications.

Zenith Healthcare Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results along with the Limited Review Report from the Statutory Auditor. The meeting was held on August 14, 2026. The company reported total income of ₹350.12 Lakhs and total expenses of ₹400.97 Lakhs for the quarter, resulting in a profit before tax of ₹-50.85 Lakhs. The financial results were prepared in accordance with Indian Accounting Standards and comply with SEBI Listing Regulations. The company operates in a single reportable segment: Pharmaceuticals Business.

Zenith Healthcare Ltd announced that its Board of Directors, in a meeting held on August 14, 2026, approved the unaudited financial results for the quarter ended June 30, 2026. The results were accompanied by a limited review report from the statutory auditors. The meeting commenced at 3:00 p.m. and concluded at 3:55 p.m. The company operates in the Pharmaceuticals Business segment.

Zenith Healthcare Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting will be held at the company's registered office in Ahmedabad. Additionally, the trading window for dealing in the company's securities will remain closed until 48 hours after the declaration of these financial results, in accordance with SEBI regulations on insider trading.

Zenith Healthcare Ltd announced the re-appointment of Mr. Mahendra C Raycha as Chairman and Managing Director for a further period of 3 years, effective July 1, 2026. This reappointment is subject to shareholder approval via special resolution at the upcoming AGM. Mr. Raycha will receive a remuneration of ₹2,00,000 per month plus other perquisites. The company also announced its AGM will be held on August 28, 2026, with August 21, 2026, fixed as the record date. The Register of Members and Share Transfer Books will be closed from August 22 to August 28, 2026.

Zenith Healthcare Ltd's Board of Directors has approved the re-appointment of Mr. Mahendra C Raycha as Chairman and Managing Director for a further period of 3 years, effective July 1, 2026. This reappointment is subject to shareholder approval via special resolution at the upcoming AGM. Mr. Raycha will receive a remuneration of ₹2,00,000 per month plus other perquisites. The company also announced the AGM date as August 28, 2026, with August 21, 2026, fixed as the record date.